|Bid||68.17 x 1800|
|Ask||68.15 x 900|
|Day's Range||67.64 - 68.80|
|52 Week Range||26.49 - 77.49|
|Beta (5Y Monthly)||1.40|
|PE Ratio (TTM)||16.21|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Additional FDA approval for Hologic's (HOLX) molecular diagnostic test is expected to aid in the diagnosis of HIV infection.
Top Ranked Growth Stocks to Buy for November 25th
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Hologic (HOLX).